Type 1 Diabetes Trial, Recruiting NCT06014879 Sponsor: Baylor College of Medicine Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT06014879
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For young people (ages 10–13) and their parent or guardian:

  • The young person has been diagnosed with type 1 diabetes (according to standard medical guidelines) for at least 6 months
  • The young person is between 10 and 13 years old at the time of signing consent
  • The young person and/or their parent or guardian speaks English or Spanish
  • The young person has had at least one blood sugar control test result (called a hemoglobin A1c) of 7.5% or higher in the past 12 months
  • The young person is already a patient at one of the clinics taking part in the study
  • The parent or legal guardian is at least 18 years old at the time of signing consent
  • The parent or legal guardian has regular access to a mobile phone that can send text messages, and a device with internet access

For teenagers (ages 14–17) contributing to video content:

  • The teenager has had type 1 diabetes for at least 1 year (self-reported)
  • The teenager is between 14 and 17 years old at the time of signing consent
  • The teenager speaks English
  • The teenager lives in the United States

For diabetes care providers:

  • The provider works at one of the diabetes care centres involved in the study

Who may not be able to join:

For young people (ages 10–13):

  • Currently being treated for a serious or significant ongoing medical condition alongside diabetes (such as cancer or cystic fibrosis)
  • Currently being treated for a serious or significant mental health or psychiatric condition
  • Currently being treated for a serious or significant developmental condition that could affect the young person's ability to understand and take part, or that could affect study results

For parents or legal guardians:

  • Currently being treated for a serious or significant ongoing medical condition (such as cancer or cystic fibrosis)
  • Currently being treated for a serious or significant mental health or psychiatric condition
  • Currently being treated for a serious or significant developmental condition that could affect their ability to understand and take part, or that could affect study results

Other reasons a family may not be able to join:

  • The family plans to move the young person's diabetes care to a different hospital or clinic within the next 6 months
  • The legal guardianship of the young person with diabetes is unclear at the time of screening or recruitment
  • The study team becomes aware of involvement with the legal system during the screening or recruitment process (confirm with trial site)

For teenagers contributing to video content:

  • The teenager or their parent has a significant psychiatric or developmental condition that would interfere with the ability to understand and take part
  • The teenager has a significant other medical condition alongside diabetes (such as cancer or cystic fibrosis) that could affect study results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marisa Hilliard, PhD, Baylor College of Medicine

Phone: 832-824-7209

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 October 2024
Est. completion
30 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Demographic and Medical Information Questionnaire; Glycemic Control - HbA1c; Glycemic Control - time-in-range; Adherence - Self-Care Inventory 2 (SCI-2); Health-Related Quality of Life (HRQOL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov